Zineb Ammous
Clinical Genetics (M.D.) · Topeka, INNPI 1174751218
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $42,480 of the $58,250 with a category attached, or 72.9%. 17 manufacturers reported payments, led by Biomarin Pharmaceutical Inc. at 34.2% of the total. 2025 is the largest year on record at $15,791, 2.6 times the $6,071 reported in 2019.
Across 106 payments — averaging $549.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biomarin Pharmaceutical Inc.$20K
- Mirum Pharmaceuticals, Inc.$17K
- Travere Therapeutics, Inc.$17K
- Modernatx, Inc.$2K
- Sarepta Therapeutics, Inc.$2K
- Cycle Pharmaceuticals Inc$395
- plus $651 from 11 others
Across 27 payments — averaging $3656.41 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biomarin Pharmaceutical Inc.$53K
- Travere Therapeutics, Inc.$31K
- Mirum Pharmaceuticals, Inc.$15K
What the payments were for
- Consulting fees$42,48073%
- Speaking & faculty fees$11,20019%
- Travel & lodging$2,2714%
- Food & beverage$2,0844%
- Education$2150%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biomarin Pharmaceutical Inc. | 28 | $19,930 |
| Mirum Pharmaceuticals, Inc. | 24 | $16,917 |
| Travere Therapeutics, Inc. | 33 | $16,807 |
| Modernatx, Inc. | 1 | $1,940 |
| Sarepta Therapeutics, Inc. | 1 | $1,610 |
| Cycle Pharmaceuticals Inc | 1 | $395 |
| Genentech USA, Inc. | 1 | $147 |
| Intrabio Inc | 2 | $134 |
| Zevra Therapeutics Inc | 2 | $78 |
| PTC Therapeutics, Inc. | 3 | $65 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $50 |
| Sunovion Pharmaceuticals Inc. | 2 | $47 |
| Amicus Therapeutics, Inc. | 2 | $44 |
| Recordati_rare_diseases_inc. | 1 | $25 |
| Orchard Therapeutics North America | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $19 |
| Sanofi | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few clinical genetics (m.d.) providers in Indianato place this figure against a meaningful peer group, so we don't.
Other clinical genetics (m.d.) in Topeka
- Luis EscobarIndianapolis$32K
- Bradley TinkleIndianapolis$3K
- Brett GrahamIndianapolis$959
- Theodore WilsonIndianapolis$299
- David WeaverIndianapolis$243
- Wilfredo Torres MartinezIndianapolis$188
- Patricia BaderFort Wayne$22
- Stephanie WareIndianapolis$14
- Gabrielle GeddesIndianapolis$0
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.